145 related articles for article (PubMed ID: 20383511)
1. Non-traumatic fracture of the femoral shaft in a patient taking long-term bisphosphonate therapy.
Ahn JK; Lee J; Cha HS; Koh EM
Rheumatol Int; 2011 Jul; 31(7):973-5. PubMed ID: 20383511
[No Abstract] [Full Text] [Related]
2. [When should bisphosphonate treatment be discontinued?].
Eriksen EF; Halse J
Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1630-2. PubMed ID: 22875131
[No Abstract] [Full Text] [Related]
3. Bisphosphonate-associated atypical subtrochanteric femur fractures in the older patient.
Gopal GK; Tam KL; Krishnan SP; Maddern IL
N Z Med J; 2014 Feb; 127(1389):81-5. PubMed ID: 24548959
[TBL] [Abstract][Full Text] [Related]
4. Bilateral low-energy sequential femoral shaft fractures in patients on long-term bisphosphonate therapy.
Çakmak S; Mahiroğulları M; Keklikçi K; Sarı E; Erdik B; Rodop O
Acta Orthop Traumatol Turc; 2013; 47(3):162-72. PubMed ID: 23748615
[TBL] [Abstract][Full Text] [Related]
5. Low-energy femoral shaft fractures associated with alendronate use.
Neviaser AS; Lane JM; Lenart BA; Edobor-Osula F; Lorich DG
J Orthop Trauma; 2008; 22(5):346-50. PubMed ID: 18448990
[TBL] [Abstract][Full Text] [Related]
6. Atypical femoral fractures associated with long-term bisphosphonate use.
Chatterjee S
CMAJ; 2013 Oct; 185(14):1248. PubMed ID: 23649415
[No Abstract] [Full Text] [Related]
7. More on atypical fractures of the femoral diaphysis.
Lee P; Seibel MJ
N Engl J Med; 2008 Jul; 359(3):317; author reply 317-8. PubMed ID: 18642421
[No Abstract] [Full Text] [Related]
8. Low-energy femoral shaft fractures after long-term alendronate therapy: report of seven cases.
Ballas EG; Mavrogenis AF; Karamanis E; Kokkalis ZT; Mitsiokapa E; Koulalis D; Mastrokalos D; Papagelopoulos PJ
Eur J Orthop Surg Traumatol; 2015 Jan; 25(1):181-7. PubMed ID: 24676887
[TBL] [Abstract][Full Text] [Related]
9. Case reports: two femoral insufficiency fractures after long-term alendronate therapy.
Sayed-Noor AS; Sjödén GO
Clin Orthop Relat Res; 2009 Jul; 467(7):1921-6. PubMed ID: 19198962
[TBL] [Abstract][Full Text] [Related]
10. Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate.
Lenart BA; Lorich DG; Lane JM
N Engl J Med; 2008 Mar; 358(12):1304-6. PubMed ID: 18354114
[No Abstract] [Full Text] [Related]
11. Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry.
Hagen JE; Miller AN; Ott SM; Gardner M; Morshed S; Jeray K; Alton TB; Ren D; Abblitt WP; Krieg JC
J Bone Joint Surg Am; 2014 Nov; 96(22):1905-9. PubMed ID: 25410509
[TBL] [Abstract][Full Text] [Related]
12. Sequential non-traumatic femoral shaft fractures in a patient on long-term alendronate.
Cheung RK; Leung KK; Lee KC; Chow TC
Hong Kong Med J; 2007 Dec; 13(6):485-9. PubMed ID: 18057440
[TBL] [Abstract][Full Text] [Related]
13. Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.
Lenart BA; Neviaser AS; Lyman S; Chang CC; Edobor-Osula F; Steele B; van der Meulen MC; Lorich DG; Lane JM
Osteoporos Int; 2009 Aug; 20(8):1353-62. PubMed ID: 19066707
[TBL] [Abstract][Full Text] [Related]
14. Femoral insufficiency fractures associated with prolonged bisphosphonate therapy.
Isaacs JD; Shidiak L; Harris IA; Szomor ZL
Clin Orthop Relat Res; 2010 Dec; 468(12):3384-92. PubMed ID: 20809164
[TBL] [Abstract][Full Text] [Related]
15. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk.
Schneider JP
Geriatrics; 2009 Jan; 64(1):18-23. PubMed ID: 19256578
[TBL] [Abstract][Full Text] [Related]
16. [Morphological analysis of bone dynamics and metabolic bone disease. Does bisphosphonate treatment cause severely suppressed bone turnover (SSBT) ?].
Kondo N; Yoda T
Clin Calcium; 2011 Apr; 21(4):583-7. PubMed ID: 21447926
[TBL] [Abstract][Full Text] [Related]
17. Low-energy femoral fractures associated with the long-term use of bisphosphonates: a case series from a Swiss university hospital.
Ing-Lorenzini K; Desmeules J; Plachta O; Suva D; Dayer P; Peter R
Drug Saf; 2009; 32(9):775-85. PubMed ID: 19670917
[TBL] [Abstract][Full Text] [Related]
18. Atypical bilateral femoral shaft fracture in patient treated with bisphosphonates.
Parrón Cambero R; Rey López A; Tomé-Bermejo F; Cibantos Martínez R
Eur J Orthop Surg Traumatol; 2013 Nov; 23 Suppl 2():S219-23. PubMed ID: 23412218
[TBL] [Abstract][Full Text] [Related]
19. Atypical femoral fractures, bisphosphonates, and mechanical stress.
Aspenberg P; Schilcher J
Curr Osteoporos Rep; 2014 Jun; 12(2):189-93. PubMed ID: 24615358
[TBL] [Abstract][Full Text] [Related]
20. Femoral shaft fractures in the elderly--role of prior bisphosphonate therapy.
Ng YH; Gino PD; Lingaraj K; Das De S
Injury; 2011 Jul; 42(7):702-6. PubMed ID: 21316051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
